• X-Ray Inspection System

    Sunstein prosecutes patents for AS&E, an industry leader in advanced detection systems, which sells products employing sophisticated x-ray imaging technology used to inspect cargo and vehicles at ports of entry for explosives and contraband.

  • Programmable Switch

    Sunstein patents protect integrated circuits, such as the synchronous switch post rotator shown here, that our clients have developed for innovative applications in computer, automotive, manufacturing and testing industries.

  • iBOT® Mobility System

    For renowned inventor Dean Kamen, Sunstein obtained patents for the iBOT® Mobility System sold by Independence Technology (a division of Johnson & Johnson), which allows the physically challenged to climb stairs and traverse uneven terrain, and, notably, to raise themselves to the level of standing persons.

  • LAV Valve

    Sunstein won a jury verdict for Abbott Laboratories and NP Medical, defeating a multi-million dollar patent infringement claim relating to intravenous valve devices. The verdict and judgement of non-infringement were affirmed by the Court of Appeals for the Federal Circuit.

Deep Patent & Trial Experience

Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co.

We participated in the representation of Ariad, obtaining a $65 million jury verdict for infringement of our client’s patents for regulating NF-kappaB cell-signaling activity, the largest verdict in Massachusetts that year.

Exergen Corporation vs. Kaz, USA, Inc.

Sunstein lawyers won a $14.6M verdict for patent infringement following a two-week jury trial for our client Exergen, the people who pioneered the temporal artery thermometer.

FairWarning IP, LLC v. Iatric, Inc.; FairWarning IP, LLC v. CynergisTek, Inc.

In both the District Court and at the Federal Circuit Court of Appeals, Sunstein successfully defended clients Iatric and CynergisTek against claims of patent infringement relating to software for detecting fraud and misuse of protected health information, obtaining judgments of patent invalidity under Section 101.

In disputes over brand names, we have also delivered major successes to our clients.

Winning at Post Grant Proceedings

Motorola Mobility LLC, Google Inc., and Apple Inc. v. Arendi S.A.R.L.

Motorola, Google and Apple attacked the same patent as Samsung raising several additional grounds. Our arguments carried the day and the inter partes review was not instituted, freeing our client’s patent for unfettered assertion in court.

Click here to learn more about Sunstein litigators.

Spotlight on Patents

A recent patent we obtained for our client Nexsan, of Santa Clara, CA,  U.S. Patent No. 9218406 covers a private cloud storage system in which security is maintained by storing the data on devices (sold under the Transporter brand) of  individual users.  Data is shared on a peer-to-peer basis.  A central  server governs access based on user privileges without storing any of  the shared data. This patent has issued in one of the fields in which recent court rulings have been propelling rapid evolution of the law.

In the News

Our Latest Thinking

  • Steven A. Abreu

    Parody protected: Louis Vuitton not only loses a trademark infringement suit against a canvas-tote maker that poked fun at the pricey bags but is faulted for lacking a sense of humor.

    More...

  • Brandon Scruggs

    No standing: A non-infringer who initiates an IPR may not be able to show sufficient stake in the outcome to appeal an adverse decision of the PTAB.

    More...

  • Nancy C. Wilker, Ph.D., J.D.W. John Keyes, Ph.D., J.D.

    Eleventh Amendment to the rescue: Sovereign immunity is ruled to protect state universities from having their patents challenged in the patent office.

    More...

  • Gozde Guckaya

    Supreme Court cheat sheet: Here’s a rundown of IP cases to be decided this term.

    More...

  • W. John Keyes, Ph.D., J.D.

    Sometimes, it takes a village to infringe a patent. The combination of doctors advising patients to take vitamins before chemotherapy and patients following that advice is held to infringe a method of administering a drug.

    More...

Free Subscription

See more in Publications/News